Skip to Content

Peter W.T. Pisters, MD, MHCM, CPE, FACS, FACHE

Present Title & Affiliation

Primary Appointment

Vice-President, Regional Care System, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement


Peter W.T. Pisters, MD, MHCM, CPE, FACS, FACHE

University of Texas MD Anderson Cancer Center

Regional Care System

Houston, TX, USA

Dr. Peter W.T. Pisters is an academic surgeon and physician executive at The University of Texas MD Anderson Cancer Center. As, a Professor of Surgery, Dr. Pisters has clinical experience and academic interest in gastric cancer, pancreatic cancer, and soft tissue sarcomas. Dr. Pisters has held leadership positions in national medical organizations and cooperative groups dedicated to advancing the science and treatment of cancer. He is also a member of the editorial board of multiple surgery and oncology journals and has authored more than 200 peer-reviewed publications and 70 book chapters.


 As Vice President and Medical Director of MD Andersonís Regional Care System, Dr. Pisters provides leadership and direction in areas that include strategy, business development, and operations for MD Andersonís regional operations.   These regional care centers are clinically integrated with MD Andersonís Texas Medical Center campus and provided services for 5200 new cancer patients in FY12.

Office Address

The University of Texas MD Anderson Cancer Center
7007 Bertner Avenue
Unit 1639
Unit Number: 1407
Houston, TX 77030
Room Number: 1MC10.2206
Phone: 713-794-1572

Education & Training

Degree-Granting Education

2014 Harvard University School of Public Health, Boston, MA, MS, Healthcare Management
1985 University of Western Ontario, London, Ontario, Canada, MD, Medicine

Postgraduate Training

7/1993-6/1994 Chief Administrative Fellow, Surgical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, Murray F. Brennan, M.D.
7/1992-6/1994 Clinical Fellowship, Surgical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, Murray F. Brennan, M.D.
7/1989-6/1992 Senior and Chief Resident, General Surgery, New York University Medical Center-Bellevue Hospital Center, New York, NY, Frank C. Spencer, M.D.
7/1987-6/1989 Research Fellowship, Surgical Metabolism Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, Murray F. Brennan, M.D.
7/1985-6/1987 Intern and Junior Resident, General Surgery, New York University Medical Center - Bellevue Hospital Center, New York, NY, Frank C. Spencer, M.D.

Board Certifications

2013 American Board of Surgery


Administrative Appointments/Responsibilities

Clinical Consultant, The University of Texas M. D. Anderson Cancer Center, Center for Global Oncology, Houston, TX, 7/2008-present

Honors and Awards

2000 Outstanding Teacher Award, U. T. M. D. Anderson Cancer Center
1998-1999 Faculty Excellence Award, U.T. M. D. Anderson Cancer Center
1997-1998 Faculty Excellence Award, U.T. M. D. Anderson Cancer Center
1997 Outstanding Teacher Award, U.T. M. D. Anderson Cancer Center
1996-1997 Faculty Excellence Award, U.T. M. D. Anderson Cancer Center

Professional Memberships

American Board of Surgery, Austin, TX
Member, Task Force, ABS Advisory, 9/2007-9/2008
Surgical Oncology Advisory Council Member, 10/2001-10/2002
Associate Examiner, 10/2000-present
American College of Health Executives, Chicago, IL
Member, 5/2011-present
American College of Physician's Executives, Tampa, FL
Member, 3/2011-present
American College of Surgeons, Chicago, IL
Member, AJCC Soft Tissue Sarcoma Task Force, 9/2007-present
American College of Surgeons Oncology Group
Co-Chair, Gastrointestinal Organ Site, 2006-present
Member, Executive Committee, 2004-present
American Surgical Association
Member, 7/2008-present
Connective Tissue Oncology Society
Program Committee, 2000
Moderator, Surgical Oncology Session, 1998
Moderator, Symposium on Early Stage Sarcoma, 1997
Member, International Database Committee, 1996-1998
Desmoid Tumor Research Foundation
Advisory Board, 2005-present
GI Stromal Tumors (GIST) Task Force, Bethesda, MD
Member, 7/2008-present
National Cancer Institute, Bethesda, MD
Reviewer for Subcommittee H, 11/2007-12/2007
National Cancer Institute (GIST Task Force), Bethdesda, MD
Member, 6/2008-present
National Cancer Institute (Pancreas Task Force), Bethesda, MD
Member, 1/2008
National Cancer Institute (Sarcoma Task Force), Bethesda, MD
Member, 1/2008
National Comprehensive Cancer Network (NCCN), Boston, MA
Member, 1/2007-present
Radiation Therapy Oncology Group
Group, Vice-Chair, Surgery, 2001-present
RTOG Steering Committee, 2001-present
Soft Tissue Sarcoma Working Group, 1999-present
Chairman, Surgical Quality Control Committee, 1999-2005
Society of Surgical Oncology
Member, Technology and Communications Committee, 5/2012-5/2015
Member, ABS Advisory Task Force, 2006-present
Member, Executive Council, 2006-present
Member, Nominating Committee, 2004
Counselor-at-Large, Executive Council, 2002-2005
Chairman, Training Committee, 1999-2002
Member, Membership Committee, 1999-2002
Member, Program Directors Committee, 1999-2002
Western Surgical Association
Advisory Nominating Committee, 2012
Member, Membership Committee, 2011-2012
District III Representative, 7/2010-2013
Executive Committee, 7/2010-2013
District Representative, 2009-2012
Member, Program Committee, 2009-2010
Chairman, Program Committee, 2008
Member, Program Committee, 2004-2008
Yonsei Cancer Center, Seoul, Korea, Republic of
External Advisory Board, 2006-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Anaya DA, Lahat G, Wang X, Xiao L, Pisters PW, Cormier JN, Hunt KK, Feig BW, Lev DC, Pollock RE. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 21(2):397-402, 2/2010. PMID: 19622598.
2. Katz MH, Fleming JB, Lee JE, Pisters PW. Current status of adjuvant therapy for pancreatic cancer. Oncologist 15(11):1205-13, 2010. e-Pub 11/2/2010. PMID: 21045189.
3. Anaya DA, Lahat G, Wang X, Xiao L, Tuvin D, Pisters PW, Lev DC, Pollock RE. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. Ann Surg Oncol 16(3):667-75, 3/2009. PMID: 19101765.
4. Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 144(3):216-21, 3/2009. PMID: 19289659.
5. Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16(4):836-47, 2/2009. PMID: 19194760.
6. Anaya DA, Lahat G, Liu J, Xing Y, Cormier JN, Pisters PWT, Lev DC, Pollock RE.. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 249(1):137-42, 2009. PMID: 19106689.
7. Badgwell B, Cormier JN, Xing Y, Yao J, Bose D, Krishnan S, Pisters PWT, Feig BW, Mansfield PF.. Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol 16(1):42-50, 11/2008. PMID: 18985270.
8. Katz MH, Fleming JB, Pisters PWT, Lee JE, Evans DB.. Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. Ann Surg 248(6):1098-102, 2008. PMID: 19092356.
9. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PWT, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. XRCC2 and XRCC3 genes polymorphism and risk of pancreatic cancer. Am J Gastroenterol 103:360-67, 2008.
10. Patel PR, Mansfield PF, Crane CH, Wu TT, Lee JH, Lynch PM, Morris J, Pisters PW, Feig B, Sunder PK, Izzo JG, Ajani JA. Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer 110(5)(5):989-95, 9/1/2007. PMID: 17636525.
11. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 67(1):158-63, 2007. PMID: 17084545.
12. Wallace MJ, Choi E, McRae S, Madoff DC, Ahrar K, Pisters PWT. Superior mesenteric artery pseudoaneurysm following pancreaticoduodenectomy: management by endovascular stent-graft placement and transluminal thrombin injection. CardioVasc Intervent Radiol 30:518-22, 2007. PMID: 17031732.
13. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13(8):1035-46, 2006. PMID: 16865597.
14. Cannon CP, Ballo MT, Zagars GK, Mirza AN, Lin PP, Lewis VO, Yasko AW, Benjamin RS, Pisters PW. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 107:2455-61, 2006. PMID: 17036354.
15. Huang X, Cormier JN, Pisters PW. Estimation of the causal effects on survival of two-stage nonrandomized treatment sequences for recurrent diseases. Biometrics 62(3):901-9, 2006. PMID: 16984334.
16. Al-Refaie WB, Choi EA, Tseng JF, Tamm EP, Lee JH, Lee JE, Evans DB, Pisters PW. Intraductal papillary mucinous neoplasms of the pancreas. Med Princ Pract 15(4):245-52, 2006. PMID: 16763389.
17. Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 13(4):582-94, 2006. PMID: 16523362.
18. Pawlik TM, Pisters PW, Mikula L, Feig BW, Hunt KK, Cormier JN, Ballo MT, Catton CN, Jones JJ, O'Sullivan B, Pollock RE, Swallow CJ. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 13:508-17, 2006. PMID: 16491338.
19. Rohatgi PR, Yao JC, Hess K, Schnirer I, Rashid A, Mansfield PF, Pisters PW, Ajani JA. Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival. Cancer 107(11):2576-80, 2006. PMID: 17075877.
20. Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24:1145-51, 2006. PMID: 16505434.
21. Ajani JA, Winter K, Okawara GS, Donohue JH, Pisters PW, Crane CH, Greskovich JF, Anne PR, Bradley JD, Willett C, Rich TA. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol 24(24):3953-8, 2006. PMID: 16921048.
22. Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27(1):103-11, 2006. PMID: 15987714.
23. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 106(7):1610-6, 2006. PMID: 16518798.
24. Raut CP, Pisters PW. Retroperitoneal sarcomas: Combined-modality treatment approaches. J Surg Oncol 94(1):81-7, 2006. PMID: 16788949.
25. Rohatgi PR, Mansfield PF, Crane CH, Wu TT, Sunder PK, Ross WA, Morris JS, Pisters PW, Feig BW, Gunderson LL, Ajani JA. Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma. Cancer 107(7):1475-82, 2006. PMID: 16944539.
26. Tseng JF, Ballo MT, Langstein HN, Wayne JD, Cormier JN, Hunt KK, Feig BW, Yasko AW, Lewis VO, Lin PP, Cannon CP, Zagars GK, Pollock RE, Pisters PW. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol 13(9):1209-15, 2006. PMID: 16952046.
27. Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14:1470-6, 2005. PMID: 15941958.
28. Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, Pisters PW, Ballo MT, Chen L, Trent J, 3rd, Burgess M, Patel S, Pollock RE, Cormier JN. Angiosarcoma of the breast. Cancer 104:2682-8, 2005. PMID: 16288486.
29. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB. Carcinoid tumors of the duodenum. Surgery 138:971-7; discussion 977-8, 2005. PMID: 16360380.
30. Yao JC, Tseng JF, Worah S, Hess KR, Mansfield PF, Crane CH, Schnirer,, II, Reddy S, Chiang SS, Najam A, Yu C, Giacco GG, Xie K, Wu TT, Feig BW, Pisters PW, Ajani JA. Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years. J Clin Oncol 23:3094-103, 2005. PMID: 15860869.
31. Pisters PW, Wolff RA, Crane CH, Evans DB. Combined-modality treatment for operable pancreatic adenocarcinoma. Oncology (Williston Park) 19:393-404, 409; discussion 409-10, 412-6, 2005. PMID: 15828554.
32. Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140:584-9, 2005. PMID: 15967906.
33. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130(5):1391-8, 2005. PMID: 16256794.
34. Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, Janjan N, Feig B, Faust J, Yao JC, Nivers R, Morris J, Pisters PW. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 23(6):1237-44, 2005. PMID: 15718321.
35. Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9(8):1094-104, 2005. PMID: 16269380.
36. Windham TC, Pisters PW. Retroperitoneal sarcomas. Cancer Control 12:36-43, 2005. PMID: 15668651.
37. Cormier JN, Huang X, Xing Y, Thall PF, Wang X, Benjamin RS, Pollock RE, Antonescu CR, Maki RG, Brennan MF, Pisters PW. Cohort analysis of 674 patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 22(22):4567-74, 11/15/2004. PMID: 15542808.
38. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys 58(5):1461-7, 4/1/2004. PMID: 15050324.
39. Porter GA, Cantor SB, Walsh GL, Rusch VW, Leung DH, DeJesus AY, Pollock RE, Brennan MF, Pisters PW. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. J Thorac Cardiovasc Surg 127:1366-72, 2004. PMID: 15115994.
40. Ajani JA, Mansfield PF, Janjan N, Morris J, Pisters PW, Lynch PM, Feig B, Myerson R, Nivers R, Cohen DS, Gunderson LL. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol 22:2774-80, 2004. PMID: 15254045.
41. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8:935-49; discussion 949-50, 2004. PMID: 15585381.
42. Pisters PW, Patel SR, Prieto VG, Thall PF, Lewis VO, Feig BW, Hunt KK, Yasko AW, Lin PP, Jacobson MG, Burgess MA, Pollock RE, Zagars GK, Benjamin RS, Ballo MT. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol 22:3375-80, 2004. PMID: 15310783.

Invited Articles

1. Muss HB, Von Roenn J, Damon LE, Deangelis LM, Flaherty LE, Harari PM, Kelly K, Kosty MP, Loscalzo MJ, Mennel R, Mitchell BS, Mortimer JE, Muggia F, Perez EA, Pisters PW, Saltz L, Schapira L, Sparano J, American Society of Clinical Oncology. ACCO: ASCO core curriculum outline. J Clin Oncol 23(9)(9):2049-77, 3/2005. PMID: 15728218.

Book Chapters

1. Pollock RE, Baker LH, Brennan MF, Coombes K, Kattan M, Kneisl JS, Krausz T, Lazar A, Lev Dina, O'sullivan B, Panicek D, Pisters PWT. Soft Tissue Sarcoma. In: AJCC Cancer Staging Manual, Seventh. Ed(s) Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti, III A. Springer-Verlag: New York, 291-314, 2010.
2. Pisters PWT, O'Sullivan B, Maki RG. Soft Tissue Sarcomas. In: Cancer Medicine. 108, 8. Ed(s) Hong WK, Bast, Jr. RC, Nait WN, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei III E. PMPH: Shelton, 1517-43, 2010.
3. Lim SJ, Pisters PWT. Stromal Tumors of the Small Bowel. In: General Surgery: Principles and International Practice. 62, 2nd. Ed(s) Bland KI, Sarr MG, Buchler MW, Csendes A, Garden OJ, Wong J,. Springer-Verlag: London, 689-97, 2010.

Last updated: 8/12/2014